Remove CalTech Remove Platform Remove Thousand Oaks Remove Venture Capital
article thumbnail

Capsida Uncloaks With $140M In Funding

socalTECH

Thousand Oaks-based Capsida Biotherapeutics, a new biotechnology company focused on using adeno-associated virus (AAV) engineering and cargo development platform to develop tissue-targeted gene therapies for multiple types of diseases, has uncloaked from stealth mode, saying it has raised $140M in total capital.